Alnylam Pharmaceuticals
ALNY
#1094
Rank
S$27.40 B
Marketcap
S$204.58
Share price
1.20%
Change (1 day)
-63.88%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company